Home LiteratureArticle Details
PMID: 7362868 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Inhibitors of complement derived from the erythrocyte membrane in paroxysmal nocturnal hemoglobinuria.

Blood ·Vol. 55 ·No. 5 ·1980-05-00 ·Pages 772-6

Chua C, Hoffmann EM, Adams JP, Rosse WF

Abstract

Extracts of the membranes of normal red cells and red cells from all subpopulations of paroxysmal nocturnal (PNH) red cells inhibited antibody-mediated complement activation. These extracts were shown to accelerate decay of the complement complex. C42, and the relative amount of inhibitory activity was similar in normal and PNH membranes. Inhibitors derived from normal red cells markedly decreased lysis of both PNH and normal cells when antibody was present in excess and complement was limiting. These same inhibitors decreased PNH cell lysis to a much lesser degree when complement was activated with cobra venom or acidified serum. The susceptibility of the PNH cell to complement lysis because of an increased fixation of C3 to its membrane is not due to a difference in membrane-associated accelerator of the decay of the C42 complex.

MeSH Terms
Animals Antibodies Complement Activation Complement Inactivator Proteins Elapid Venoms/pharmacology Erythrocyte Membrane/immunology Erythrocytes/immunology Guinea Pigs Hemoglobinuria, Paroxysmal/immunology Hemolysis Humans Sheep
Chemicals
Antibodies Complement Inactivator Proteins Elapid Venoms
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Chua C
Hoffmann E M
Adams J P
Rosse W F
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
1980-05-00
Pages
772-6
Language
English
Region
United States
NLM ID
7603509
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]